BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)

Every figure this model derived for BFNH, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2019-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 307 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 2,153,550 AssetsCurrent 2026-06-30
current liabilities 84,767 LiabilitiesCurrent 2026-06-30
equity 2,303,308 StockholdersEquity 2026-06-30
revenue 17,774 Revenues 2019-12-31
sbc 158,000,000 ShareBasedCompensation 2020-09-30

The ratios

The figures themselves rather than their scores — what somebody looking up BFNH on one particular measure came for.

RatioValue
current ratio25.41
current ratio reported25.41
operating margin-261.83
revenue growth8.98
revenue growth per share8.98
roic-1.6
rule of 40-252.86

What to be careful about

What this model itself distrusts about BFNH's figures. Written by the derivation as it ran, not added afterwards.